{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:08:43Z","timestamp":1778623723595,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/10614-0"],"award-info":[{"award-number":["2018\/10614-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/08598-9"],"award-info":[{"award-number":["2019\/08598-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jcf.2020.01.013","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T01:11:15Z","timestamp":1581556275000},"page":"575-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9457-0156","authenticated-orcid":false,"given":"Renan M.","family":"Mauch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo C\u00e9sar M.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos E.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 D.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio F.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"H\u00f8iby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos T.","family":"Nolasco da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2020.01.013_bib0001","series-title":"Cystic fibrosis foundation patient registry 2017 annual data report","year":"2018"},{"key":"10.1016\/j.jcf.2020.01.013_bib0002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40506-016-0092-6","article-title":"Nontuberculous Mycobacteria in cystic fibrosis","volume":"8","author":"Skolnik","year":"2016","journal-title":"Curr Treat Options Infect Dis"},{"key":"10.1016\/j.jcf.2020.01.013_bib0003","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","article-title":"Nontuberculous mycobacteria: I: multicenter prevalence study in cystic fibrosis","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2020.01.013_bib0004","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3201\/eid1403.061405","article-title":"Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel","volume":"14","author":"Levy","year":"2008","journal-title":"Emerging Infect. Dis."},{"key":"10.1016\/j.jcf.2020.01.013_bib0005","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France","volume":"47","author":"Roux","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcf.2020.01.013_bib0006","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3201\/eid1907.120615","article-title":"Prevalence of nontuberculous mycobacteria in cystic fibrosis clinics, United Kingdom, 2009","volume":"19","author":"Seddon","year":"2013","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.jcf.2020.01.013_bib0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcf.2014.08.002","article-title":"Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia","volume":"14","author":"Qvist","year":"2015","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2020.01.013_bib0008","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jcf.2015.09.007","article-title":"Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis","volume":"15","author":"Qvist","year":"2016","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2020.01.013_bib0009","series-title":"The Brazilian cystic fibrosis patient registry 2016","year":"2016"},{"key":"10.1016\/j.jcf.2020.01.013_bib0010","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/fty051","article-title":"Prevalence and clinical outcomes of nontuberculous mycobacteria in a Brazilian cystic fibrosis reference center","volume":"76","author":"Aiello","year":"2018","journal-title":"Pathog Dis"},{"key":"10.1016\/j.jcf.2020.01.013_bib0011","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2019.00234","article-title":"BCG vaccination induces M. avium and M. abscessus cross-protective immunity","volume":"10","author":"Abate","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcf.2020.01.013_bib0012","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-1759(96)00085-3","article-title":"A new method for measuring lymphoproliferation at the single-cell level in whole blood culture by flow cytometry","volume":"195","author":"Gaines","year":"1996","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jcf.2020.01.013_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0043438","article-title":"Immune responses to ESAT-6 and CFP-10 by Fascia and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker","volume":"7","author":"Borgstr\u00f6m","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcf.2020.01.013_bib0014","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/QAD.0b013e32834bba0a","article-title":"Impaired Bacillus Calmette-Gu\u00e9rin cellular immune response in HIV-exposed, uninfected infants","volume":"25","author":"Mazzola","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jcf.2020.01.013_bib0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/cyto.a.22995","article-title":"Elimination of erroneous results in flow cytometry caused by antibody binding to Fc receptors on human monocytes and macrophages","volume":"89","author":"Andersen","year":"2016","journal-title":"Cytometry A"},{"key":"10.1016\/j.jcf.2020.01.013_bib0016","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection","volume":"18","author":"Simmons","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcf.2020.01.013_bib0017","first-page":"93","article-title":"3835 Immune response to Mycobacterium tuberculosis in patients with human immunodeficiency virus vertical infection","volume":"46","author":"Alves","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jcf.2020.01.013_bib0018","unstructured":"BCG World Atlas n.d. http:\/\/www.bcgatlas.org\/ (accessed October 14, 2019)."},{"key":"10.1016\/j.jcf.2020.01.013_bib0019","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1473-3099(04)01130-2","article-title":"Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy","volume":"4","author":"Karakousis","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcf.2020.01.013_bib0020","first-page":"1509","article-title":"Mortality among patients with tuberculosis and associations with HIV","volume":"59","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.jcf.2020.01.013_bib0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrmicro.2017.128","article-title":"Pathogenesis of HIV-1 and mycobacterium tuberculosis co-infection","volume":"16","author":"Bell","year":"2018","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jcf.2020.01.013_bib0022","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7150\/ijbs.7823","article-title":"\u03b3\u03b4 T cells and their potential for immunotherapy","volume":"10","author":"Wu","year":"2014","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jcf.2020.01.013_bib0023","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/00365540110026584","article-title":"Cytolytic T cells in the immune response to mycobacterium tuberculosis","volume":"33","author":"Stenger","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jcf.2020.01.013_bib0024","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","article-title":"Flynn JAL. CD8 T cells and Mycobacterium tuberculosis infection","volume":"37","author":"Lin","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jcf.2020.01.013_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003119","article-title":"Granzyme a produced by \u03b39\u03b42 T cells induces human macrophages to inhibit growth of an intracellular pathogen","volume":"9","author":"Spencer","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcf.2020.01.013_bib0026","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccm.2015.11.010","article-title":"Innate and adaptive immunity in cystic fibrosis","volume":"37","author":"Bruscia","year":"2016","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.jcf.2020.01.013_bib0027","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/00365540110026584","article-title":"Cytolytic T cells in the immune response to mycobacterium tuberculosis","volume":"33","author":"Stenger","year":"2001","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.jcf.2020.01.013_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-017-2448-z","article-title":"Cystic fibrosis carriership and tuberculosis: hints toward an evolutionary selective advantage based on data from the Brazilian territory","volume":"17","author":"Bosch","year":"2017","journal-title":"BMC Infect Dis"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932030045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932030045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:14:28Z","timestamp":1778620468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932030045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S156919932030045X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2020.01.013","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte responses to Mycobacterium tuberculosis and Mycobacterium bovis are similar between BCG-vaccinated patients with cystic fibrosis and healthy controls","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2020.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}